Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Shuttle services for senior medical students
2011-09-26

 

Senior medical students who make use of the shuttle services are standing next to the mini-bus.

On Friday, 30 September 2011, our university will officially launch its shuttle service for medical students. This function will take place from 12:00 to 13:00 at the Faculty of Health Sciences’ CJC Nel Reception Venue in the Francois Retief Building on our Bloemfontein Campus.

Two years ago. Dr Scarpa Schoeman began working at Internal Medicine at our Faculty of Health Sciences. Early on, he identified the transport problems of fourth- and fifth-year medical students (Phase-3 students) in the English class.
 
There are 65 Phase-3 students in the English class who are currently struggling with transport and who are part of this project. About 90% of them are bursary students at the university who, according to Schoeman, are consequently also struggling with finances. These students used public transport like taxis to move between hospital rounds and classes in the past. On average, it would cost them up to R4 000 per year for these daily travels between the UFS and the various training hospitals.
 
By the end of March 2011, NetCare had donated two mini-busses to the UFS and since 11 April, the shuttle services were available to medical students. Prof. Gert van Zyl (Dean of our Faculty of Health Sciences), Mr Mickey Gordon (Head: Marketing, Institutional Advancement and Sport) and the Rector, Prof. Jonathan Jansen, negotiated with NetCare. Gordon was also responsible for the branding of the busses. PPS and Pfizer are both sponsors who contributed to this.
 
This project is managed by Dr Schoeman, assisted by Mrs Anne-Marie Nel, who handles the administration as the Phase-3 secretary.
 
“It is important for us from the project management that students won’t see this as another taxi, but as a shuttle service of the university. Any senior medical student may make use of it, but it is mainly the under-privileged student from the English class who makes use of it.”
 
The two Quantum mini-busses do the circuit according to fixed schedules each day.  The route starts at the Francois Retief Building on our Bloemfontein Campus and then travels to the National Hospital, the Free State Psychiatric Complex (Oranje), Pelonomi, 3 Military Hospital (at Tempe) and then back again to Universitas Hospital.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept